Continuous Glucose Monitors - Medical Devices Pipeline Assessment, 2020

Continuous Glucose Monitors - Medical Devices Pipeline Assessment, 2020

Summary

The Medical Devices sector report, “Continuous Glucose Monitors - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Continuous Glucose Monitors pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Continuous glucose monitoring system is used for the continuous measurement of blood glucose.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

Extensive coverage of the Continuous Glucose Monitors under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Continuous Glucose Monitors and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Identify and understand important and diverse types of Continuous Glucose Monitors under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date

1 Table of Contents

1.1 List of Tables
1.2 List of Figures

2 Introduction

2.1 Continuous Glucose Monitors Overview

3 Products under Development

3.1 Continuous Glucose Monitors - Pipeline Products by Stage of Development
3.2 Continuous Glucose Monitors - Pipeline Products by Territory
3.3 Continuous Glucose Monitors - Pipeline Products by Regulatory Path
3.4 Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
3.5 Continuous Glucose Monitors - Ongoing Clinical Trials

4 Continuous Glucose Monitors - Pipeline Products under Development by Companies

4.1 Continuous Glucose Monitors Companies - Pipeline Products by Stage of Development
4.2 Continuous Glucose Monitors - Pipeline Products by Stage of Development

5 Continuous Glucose Monitors Companies and Product Overview6 Continuous Glucose Monitors- Recent Developments

7 Appendix

7.1 Methodology
7.2 About the Publisher
7.3 Contact
7.4 Disclaimer

List of Tables

Table 1: Continuous Glucose Monitors - Pipeline Products by Stage of Development
Table 2: Continuous Glucose Monitors - Pipeline Products by Territory
Table 3: Continuous Glucose Monitors - Pipeline Products by Regulatory Path
Table 4: Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
Table 5: Continuous Glucose Monitors - Ongoing Clinical Trials
Table 6: Continuous Glucose Monitors Companies - Pipeline Products by Stage of Development
Table 7: Continuous Glucose Monitors - Pipeline Products by Stage of Development
Table 8: Abbott Diabetes Care Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 9: Freestyle Libre Connected Insulin Pen - Product Status
Table 10: Freestyle Libre Connected Insulin Pen - Product Description
Table 11: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Status
Table 12: FreeStyle Libre Flash Glucose Monitoring System - Children - Product Description
Table 13: Abbott Diabetes Care Inc - Ongoing Clinical Trials Overview
Table 14: FreeStyle Libre Flash Glucose Monitoring System - Children - FreeStyle Libre Flash Glucose Monitoring System Post Approval Study for Pediatric Patients
Table 15: FreeStyle Libre Flash Glucose Monitoring System - Children - Patients Perceptions of Using the Libre System Compared with Conventional SMBG in Adolescents with Type 1 Diabetes the Libre Sat Trial
Table 16: Advanced Biosensors-Ohio LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 17: My Medibit - Product Status
Table 18: My Medibit - Product Description
Table 19: Advanced Medical Electronics Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 20: Continuous Glucose Monitor - Product Status
Table 21: Continuous Glucose Monitor - Product Description
Table 22: Arkal Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 23: GlucoPod CGM System - Product Status
Table 24: GlucoPod CGM System - Product Description
Table 25: Azurite Technologies, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 26: Blood Glucose Sensor - Product Status
Table 27: Blood Glucose Sensor - Product Description
Table 28: Biorasis Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 29: Glucowizzard - Product Status
Table 30: Glucowizzard - Product Description
Table 31: Biovotion AG Pipeline Products & Ongoing Clinical Trials Overview
Table 32: VSM 3 Glucose Monitoring System - Product Status
Table 33: VSM 3 Glucose Monitoring System - Product Description
Table 34: Brigham and Women's Hospital Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Continuous Glucose Monitoring Sensor - Product Status
Table 36: Continuous Glucose Monitoring Sensor - Product Description
Table 37: CALISTO MEDICAL, INC. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Glucoband - Product Status
Table 39: Glucoband - Product Description
Table 40: CGM3 Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Miniaturized Implantable Continuous Glucose Monitor - Product Status
Table 42: Miniaturized Implantable Continuous Glucose Monitor - Product Description

List of Figures

Figure 1: Continuous Glucose Monitors - Pipeline Products by Stage of Development
Figure 2: Continuous Glucose Monitors - Pipeline Products by Territory
Figure 3: Continuous Glucose Monitors - Pipeline Products by Regulatory Path
Figure 4: Continuous Glucose Monitors - Pipeline Products by Estimated Approval Date
Figure 5: Continuous Glucose Monitors - Ongoing Clinical Trials